Moving on to the first step of the risk assessment. This involves identifying the novel traits that are expressed by the LMO and whether or not they potentially pose any adverse effects on the likely potential receiving environment.

The first step of the risk assessment is “an identification of any novel genotypic and phenotypic characteristics associated with the LMO that may have adverse effects on biological diversity in the likely potential receiving environment, taking into account risks to human health”.